{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:53:21Z","timestamp":1762541601589},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Biochemical Parasitology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.molbiopara.2007.04.009","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:21Z","timestamp":1177153821000},"page":"70-81","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs"],"prefix":"10.1016","volume":"154","author":[{"given":"Jan M.","family":"Woynarowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Krugliak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagai","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbiopara.2007.04.009_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","article-title":"The global distribution of clinical episodes of Plasmodium falciparum malaria","volume":"434","author":"Snow","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/415694a","article-title":"Progress and challenges for malaria vaccines","volume":"415","author":"Richie","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1471-4922(02)00017-X","article-title":"Malaria control and the evolution of drug resistance: an intriguing link","volume":"19","author":"Hastings","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1286-4579(01)01523-4","article-title":"Clinical status and implications of antimalarial drug resistance","volume":"4","author":"Winstanley","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.1073126","article-title":"Drugs to combat tropical protozoan parasites","volume":"297","author":"Gelb","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728222.5.4.423","article-title":"Emerging targets for antimalarial drugs","volume":"5","author":"Padmanaban","year":"2001","journal-title":"Exp Opin Ther Targets"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0166-6851(93)90085-C","article-title":"Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands","volume":"58","author":"Ginsburg","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0163-7258(97)00095-8","article-title":"Antimalarial activity of synthetic analogues of distamycin","volume":"76","author":"Lombardi","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib10","first-page":"1","article-title":"Preferential damage to defined regions of genomic DNA by AT-specific anticancer drugs","volume":"vol. 4","author":"Woynarowski","year":"2002"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0925-4439(02)00093-5","article-title":"Targeting critical regions in genomic DNA with AT-specific anticancer drugs","volume":"1587","author":"Woynarowski","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib12","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1021\/bi000729k","article-title":"Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity","volume":"39","author":"Woynarowski","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1568009043481524","article-title":"AT islands\u2014their nature and potential for anticancer strategies","volume":"4","author":"Woynarowski","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00001813-199810000-00006","article-title":"Phase II study of adozelesin in untreated metastatic breast cancer","volume":"9","author":"Cristofanilli","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/86.5.368","article-title":"Phase I study of adozelesin administered by 24h continuous intravenous infusion","volume":"86","author":"Fleming","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib16","first-page":"712","article-title":"A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors","volume":"8","author":"Pitot","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdg215","article-title":"A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies","volume":"14","author":"Schwartz","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2307\/3283622","article-title":"In vitro sensitivity of Plasmodium falciparum to drugs that bind DNA or inhibit its synthesis","volume":"79","author":"Lee","year":"1993","journal-title":"J Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2006.02.019","article-title":"The A\/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection","volume":"148","author":"Yanow","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1021\/bi00061a017","article-title":"Nucleotide preferences for DNA interstrand cross-linking induced by the cyclopropylpyrroloindole analogue U-77,779","volume":"32","author":"Lee","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib21","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1021\/ja00067a005","article-title":"Analysis of the monoalkylation and cross-linking sequence specificity of bizelesin, a bifunctional alkylation agent related to (+)-CC-1065","volume":"115","author":"Sun","year":"1993","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib22","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/bi00244a027","article-title":"In vitro and in vivo DNA bonding by the CC-1065 analogue U-73975","author":"Weiland","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-4781(99)00002-0","article-title":"Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA","volume":"1444","author":"Woynarowski","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00686039","article-title":"Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065","volume":"34","author":"Walker","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib25","doi-asserted-by":"crossref","first-page":"40555","DOI":"10.1074\/jbc.M103390200","article-title":"AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs","volume":"276","author":"Woynarowski","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/bi011907s","article-title":"The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A\/T-G\/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level","volume":"41","author":"Herzig","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib27","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1093\/nar\/gkg832","article-title":"Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells","volume":"31","author":"Jackson","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-2952(93)90511-T","article-title":"The susceptibility of the malarial parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes","volume":"46","author":"Shalmiev","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0024-3205(91)90133-V","article-title":"Studies on the antimalarial mode of action of quinoline-containing drugs: time-dependence and irreversibility of drug action, and interactions with compounds that alter the function of the parasite's food vacuole","volume":"49","author":"Krugliak","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib32","doi-asserted-by":"crossref","first-page":"14045","DOI":"10.1021\/bi991286r","article-title":"Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific","volume":"38","author":"Herzig","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/nar\/27.2.573","article-title":"Tandem repeats finder: a program to analyze DNA sequences","volume":"27","author":"Benson","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature04979","article-title":"A genomic code for nucleosome positioning","volume":"442","author":"Segal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4269\/ajtmh.1989.40.240","article-title":"Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture","volume":"40","author":"Geary","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"ter Kuile","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4269\/ajtmh.2002.66.661","article-title":"In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives","volume":"66","author":"Pradines","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/mol.54.5.770","article-title":"Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA","volume":"54","author":"Woynarowski","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/MMBR.67.3.360-375.2003","article-title":"Repetitive elements in genomes of parasitic protozoa","volume":"67","author":"Wickstead","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/med.10051","article-title":"The thioredoxin system\u2014from science to clinic","volume":"24","author":"Gromer","year":"2004","journal-title":"Med Res Rev"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/ars.2006.8.1227","article-title":"Thioredoxin networks in the malarial parasite Plasmodium falciparum","volume":"8","author":"Nickel","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib42","first-page":"439","article-title":"In silico and wet-bench identification of nuclear matrix attachment regions","volume":"108","author":"Krawetz","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1134\/S0006297906050038","article-title":"Scaffold\/matrix attachment regions and intrinsic DNA curvature","volume":"71","author":"Fiorini","year":"2006","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib44","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.0510363103","article-title":"Evidence on the chromosomal location of centromeric DNA in Plasmodium falciparum from etoposide-mediated topoisomerase-II cleavage","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0169-4758(95)80006-9","article-title":"The sticky secrets of sequestration","volume":"11","author":"Sherman","year":"1995","journal-title":"Parasitol Today"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10096-004-1113-9","article-title":"Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections","volume":"23","author":"Edwards","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/nar\/24.5.824","article-title":"A repair competition assay to assess recognition by human nucleotide excision repair","volume":"24","author":"Hess","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib49","first-page":"5690","article-title":"In vivo mutagenesis induced by CC-1065 and adozelesin DNA alkylation in a transgenic mouse model","volume":"53","author":"Monroe","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7883\/yoken1952.47.241","article-title":"Cure with cisplatin (II) or murine malaria infection and in vitro inhibition of a chloroquine-resistant Plasmodium falciparum isolate","volume":"47","author":"Nair","year":"1994","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib51","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1046\/j.1432-1327.2000.01703.x","article-title":"Thioredoxin reductase as a pathophysiological factor and drug target","volume":"267","author":"Becker","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molbiopara.2007.04.009_bib52","first-page":"1086","article-title":"Unwound nature of MAR-capable AT-rich DNA domains (AT-islands) targeted by a highly AT-specific drug bizelesin","volume":"47","author":"Woynarowski","year":"2006","journal-title":"Proc. Amer. Assoc. Cancer Res."}],"container-title":["Molecular and Biochemical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685107001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685107001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T12:28:16Z","timestamp":1556368096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166685107001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0166685107001132"],"URL":"https:\/\/doi.org\/10.1016\/j.molbiopara.2007.04.009","relation":{},"ISSN":["0166-6851"],"issn-type":[{"value":"0166-6851","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}